Cargando…

Emerging trends in plasma‐free manufacturing of recombinant protein therapeutics expressed in mammalian cells

Mammalian cells are the expression system of choice for therapeutic proteins, especially those requiring complex post‐translational modifications. Traditionally, these cells are grown in medium supplemented with serum and other animal‐ or human‐derived components to support viability and productivit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grillberger, Leopold, Kreil, Thomas R., Nasr, Sonia, Reiter, Manfred
Formato:	Texto
Lenguaje:	English
Publicado:	WILEY‐VCH Verlag 2009
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699044/ https://www.ncbi.nlm.nih.gov/pubmed/19226552 http://dx.doi.org/10.1002/biot.200800241

Ejemplares similares

Nanofiltration as a robust method contributing to viral safety of plasma‐derived therapeutics: 20 yearsʼ experience of the plasma protein manufacturers
por: Roth, Nathan J., et al.
Publicado: (2020)

Avian cell line - Technology for large scale vaccine production
por: Kraus, Barbara, et al.
Publicado: (2011)

A double-inactivated whole virus candidate SARS coronavirus vaccine stimulates neutralising and protective antibody responses
por: Spruth, Martin, et al.
Publicado: (2006)

A Whole Virus Pandemic Influenza H1N1 Vaccine Is Highly Immunogenic and Protective in Active Immunization and Passive Protection Mouse Models
por: Kistner, Otfried, et al.
Publicado: (2010)

Omicron Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization by Immunoglobulin Preparations Manufactured From Plasma Collected in the United States and Europe( )
por: Farcet, Maria R, et al.
Publicado: (2022)

Advances in recombinant antibody manufacturing
por: Kunert, Renate, et al.
Publicado: (2016)

Progress of Transposon Vector System for Production of Recombinant Therapeutic Proteins in Mammalian Cells
por: Wei, Mian, et al.
Publicado: (2022)

Plasma long-chain free fatty acids predict mammalian longevity
por: Jové, Mariona, et al.
Publicado: (2013)

Emerging vaccine manufacturers are innovating for the next decade
por: Hayman, Benoit, et al.
Publicado: (2020)

Emerging Strategies to Improve the Design and Manufacturing of Biocompatible Therapeutic Materials
por: Martínez, Guillermo, et al.
Publicado: (2023)

Cost of Manufacturing for Recombinant Snakebite Antivenoms
por: Jenkins, Timothy Patrick, et al.
Publicado: (2020)

Centromere mitotic recombination in mammalian cells
por: Jaco, Isabel, et al.
Publicado: (2008)

Plasma procurement and plasma product safety in light of the COVID‐19 pandemic from the perspective of the plasma industry
por: Turecek, Peter L., et al.
Publicado: (2022)

PLASMA MEMBRANES OF MAMMALIAN CELLS : A Review of Methods for Their Characterization and Isolation
por: DePierre, Joseph W., et al.
Publicado: (1973)

Multiplexed expression and screening for recombinant protein production in mammalian cells
por: Chapple, Susan DJ, et al.
Publicado: (2006)

Emerging nanotechnologies for manufacturing
por: Ahmed, Waqar, et al.
Publicado: (2009)

Current Trends in Micro and Nano Manufacturing
por: Valentinčič, Joško
Publicado: (2022)

Sugar Matters: Improving In Vivo Clearance Rate of Highly Glycosylated Recombinant Plasma Proteins for Therapeutic Use
por: Zeerleder, Sacha, et al.
Publicado: (2021)

Emerging Trends in Biodegradable Microcarriers for Therapeutic Applications
por: Handral, Harish K., et al.
Publicado: (2023)

Evaluation of Virus-Free Manufacture of Recombinant Proteins Using CRISPR-Mediated Gene Disruption in Baculovirus-Infected Insect Cells
por: Bruder, Mark R., et al.
Publicado: (2023)

Baculovirus expression systems for production of recombinant proteins in insect and mammalian cells
por: Beljelarskaya, S. N.
Publicado: (2011)

Therapeutic protein transduction of mammalian cells and mice by nucleic acid-free lentiviral nanoparticles
por: Link, Nils, et al.
Publicado: (2006)

Roadmap for strengthening the vaccine supply chain in emerging countries: Manufacturers' perspectives
por: Jarrett, Stephen, et al.
Publicado: (2020)

The Manufacturing of High Porosity Iron with an Ultra-Fine Microstructure via Free Pressureless Spark Plasma Sintering
por: Cui, Guodong, et al.
Publicado: (2016)

Fast Track to Waste-Free Manufacturing
por: Davis, John
Publicado: (2020)

New trends in Manufacturing Systems Research 2020
por: Fratini, Livan, et al.
Publicado: (2020)

New Trends in Manufacturing Processes Research 2020
por: Fratini, Livan, et al.
Publicado: (2020)

Emerging Materials for Additive Manufacturing
por: Sing, Swee Leong, et al.
Publicado: (2022)

Sequestration of Mammalian Rad51-Recombination Protein into Micronuclei
por: Haaf, Thomas, et al.
Publicado: (1999)

SPIDR is required for homologous recombination during mammalian meiosis
por: Huang, Tao, et al.
Publicado: (2023)

Emerging Trends in Hepatocellular Carcinoma: Focus on Diagnosis and Therapeutics
por: Flores, Avegail, et al.
Publicado: (2014)

Improved Titer in Late-Stage Mammalian Cell Culture Manufacturing by Re-Cloning
por: He, Qin, et al.
Publicado: (2022)

Manufacturing of recombinant adeno-associated viral vectors for clinical trials
por: Clément, Nathalie, et al.
Publicado: (2016)

Evaluation of the Influenza A Replicon for Transient Expression of Recombinant Proteins in Mammalian Cells
por: Krammer, Florian, et al.
Publicado: (2010)

High-Level Expression of Palmitoylated MPP1 Recombinant Protein in Mammalian Cells
por: Chytła, Agnieszka, et al.
Publicado: (2021)

The potential of cold-shock promoters for the expression of recombinant proteins in microbes and mammalian cells
por: Bartolo-Aguilar, Yaneth, et al.
Publicado: (2022)

West Nile Virus Infection in Plasma of Blood and Plasma Donors, United States
por: Planitzer, Christina B., et al.
Publicado: (2009)

Adipose stromal cells bioproducts as cell-free therapies: manufacturing and therapeutic dose determine in vitro functionality
por: Skovronova, Renata, et al.
Publicado: (2023)

Selection of recombinant MVA by rescue of the essential D4R gene
por: Ricci, Patricia S, et al.
Publicado: (2011)

Antibody‐enhanced hepatitis E virus nanofiltration during the manufacture of human immunoglobulin
por: Kapsch, Anna‐Maria, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_oepspoi49n0ocdfiu9hnjl01dm